Neurology News

Recent data revealed an increase in medication use among nursing home residents in Ontario, Canada, “with the potential for adverse effects” during the COVID-19 pandemic, according to researchers.

Decreased levels of plasma amyloid beta 42 at midlife, but not late life, correlated with an increased risk for dementia and a “marginally higher” risk for mild cognitive impairment, according to findings published in Neurology.

Five newer antiseizure medications approved since 2008 did not increase suicidality risk among people with epilepsy, according to results of a meta-analysis published in JAMA Neurology.

A project that restructured primary care health professional shortage area designations could improve the distribution of primary care clinicians and resources in the United States, according to a recent analysis in JAMA Network Open.

In this episode, Priya U. Kumthekar, MD, discusses her entry into the field of neuro-oncology, her insight into translational medicine and its applications outside of medicine, and more.

The FDA today approved Nexviazyme, an IV infusion, for the treatment of late-onset Pompe disease among patients aged 1 year and older, according to a press release.

Neurodegenerative disease diagnoses occurred more often among former soccer players than the general population, with defenders experiencing the highest risk, according to results of a cohort study published in JAMA Neurology.

In a recent survey, patients said they viewed physicians in casual attire such as a fleece jacket in place of a white coat as less professional and less experienced.

The death of Lorna Breen, MD, FAEP, the New York-Presbyterian Allen Hospital clinician who took her own life in April 2020, drew new attention to physician suicide, and led to an act of legislation that bears her name.

Experiences of racial discrimination appeared linked to disproportionately greater response in brain regions related to emotion regulation, fear inhibition and visual attention among Black women.